Product Candidates/Indications	Research	Pre-clinical	Phase 1
BNZ-1 (IL-2, IL-9, IL-15)
T-cell Leukemia’s including Large Granular Leukemia (LGL) and Cutaneous T-cell Leukemia (CTCL)	80%
BNZ-2 (IL-15, IL-21)
Celiac Disease (oral)	50%
Inflammatory Bowel Disease (s.c.)	28%
BNZ-3 (IL-4, IL-9, IL-21)
Autoimmune Disorders	20%

Product Candidates/Indications	Phase
BNZ-1 (IL-2, IL-15)
T-cell Leukemia’s including Large Granular Leukemia (LGL) and Cutaneous T-cell Leukemia (CTCL)	Phase 1
BNZ-2 (IL-15, IL-21)
Celiac Disease (oral)	Pre-Clinical
Inflammatory Bowel Disease (s.c.)	Research
BNZ-3 (IL-4, IL-9, IL-21)
Autoimmune Disorders	Research